Sebaceous adenitis – aktualne wytyczne dla diagnostyki i terapii
Piśmiennictwo
Cosgrove S.B., Wren J.A., Cleaver D.M., Martin D.D., Walsh K.F., Harfst J.A., Follis S.L., King V.L., Boucher J.F., Stegemann M.R.: Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis. „Vet Dermatol”, 2013, 24, 479-e114.
Dunstan R.W., Hargis A.M.: The diagnosis of sebaceous adenitis in standard poodle dogs. [In:] Bonagura J.D., Kirk R.W. (eds.): Kirk’s Current Veterinary Therapy XII. Philadelphia, Pennsylvania, WB Saunders, 1995, 619-622.
Frazer M.M., Schick A.E., Lewis T.P., Jazic E.: Sebaceous adenitis in Havanese dogs: a retrospective study of the clinical presentation. „Vet Derm”, 2011, 22, 3.
Jassies-van der Lee A., van Zeeland Y., Kik M., Schoemaker N.: Successful treatment of sebaceous adenitis in a rabbit with ciclosporin and triglycerides. „Vet Dermatol”, 2009, 20, 67-71.
Lam A.T., Affolter V.K., Outerbridge C.A., Gericota B., White S.D.: Oral vitamin A as an adjunct treatment for canine sebaceous adenitis. „Vet Dermatol”, 2011, 22, 305-11.
Linek M., Boss C., Haemmerling R., Hewicker-Trautwein M., Mecklenberg L.: Effects of cyclosporine A on clinical and histologic abnormalities in dogs with sebaceous adenitis. „J Am Vet Med Assoc”, 2005, 226, 59-64.
Lortz J., Favrot C., Mecklenburg L., Nett C., Rufenacht S., Seewald W., Linek M.: A multicentre placebo-controlled clinical trial on the efficacy of oral cyclosporin A in the treatment of canine idiopathic sebaceous adenitis in comparison with conventional topical treatment. „Vet Dermatol”, 2010, 21, 593-601.
Mueller R.S., Bettenay S.V., Vogelnest L.: Sebaceous adenitis in three German Shepherd Dogs. „Aust Vet Pract”, 2001, 31, 110-114.
9. Noli C., Toma S.: Three cases of immune-mediated adnexal skin disease treated with cyclosporin. „Vet Dermatol” 2006, 17, 85-92.
Osborne C.: Sebaceous adenitis in a 7-year-old Arabian gelding. „Can Vet J”, 2006, 47, 583-586.
Paszkiewicz M.K.: ...
którzy są subskrybentami naszego portalu.
i ciesz się dostępem do bazy merytorycznej wiedzy!
